Skip to main content

Day: May 20, 2025

Mesa Air Group Reports Second Quarter Fiscal 2025 Results

PHOENIX, May 20, 2025 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today reported second quarter fiscal 2025 financial and operating results. Second Quarter Fiscal 2025 Update:Total operating revenues of $94.7 million Pre-tax loss of $62.5 million, net loss of $58.6 million, or $(1.42) per diluted share Adjusted net loss1 of $2.9 million2 excludes a $53.8 million loss related to the impairment and loss on sale of assets Adjusted EBITDAR1 of $9.6 million Operated at a 99.9% controllable completion factor3 Scheduled utilization for the quarter of 9.4 block hours per day Operated our last CRJ-900 flight on February 28, 2025“In the March 2025 quarter, Mesa posted our sixth straight quarter of positive EBITDA and EBITDAR performance, along with our third consecutive quarter of improving block-hour-per-day...

Continue reading

Talonvest Negotiates $51,317,000 Acquisition Loan for Texas Storage Portfolio

NEWPORT BEACH, CA., May 20, 2025 (GLOBE NEWSWIRE) — Talonvest Capital, Inc., a boutique commercial real estate mortgage brokerage firm, is pleased to announce the successful closing of a $51,317,000 acquisition loan on behalf of Reframe Holdings (Reframe). Reframe acquired eight-property institutional quality self-storage facilities, known as the Steelcreek Portfolio, located in key markets of Dallas, Austin, and Houston, TX. The portfolio has approximately 620,000 net rentable square feet of self-storage units, covered and uncovered parking spaces, small bay industrial units and inline retail. Reframe’s business plan for the portfolio post-closing is to rebrand the assets with third party management provided by Extra Space Storage (6 facilities) and CubeSmart (2 facilities) and improve the properties through targeted capital expenditures. Talonvest...

Continue reading

Carlyle Credit Income Fund Announces Second Quarter Financial Results and Declares Monthly Common and Preferred Dividends

NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) — Carlyle Credit Income Fund (“we,” “us,” “our,” “CCIF” or the “Fund”) (NYSE: CCIF) today announced its financial results for its second quarter ending March 31, 2025. The full detailed presentation of the Fund’s second quarter 2025 financial results can be viewed on the Fund’s website (carlylecreditincomefund.com/investor-dashboard). Nishil Mehta, CCIF’s Principal Executive Officer and President said, “Our second quarter results reflect the resilient nature of the loan and CLO market amidst a shifting macroeconomic environment. We believe the fund’s portfolio is well positioned to withstand the current market volatility as we continue to focus on optimizing our CLO positions including completing 13 accretive refinancings and resets in the quarter. We have maintained a stable monthly dividend,...

Continue reading

Viasat Releases Fourth Quarter and Fiscal Year 2025 Financial Results

CARLSBAD, Calif., May 20, 2025 (GLOBE NEWSWIRE) — Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today published its fourth quarter and fiscal year 2025 financial results in a letter to shareholders, which, along with webcast slides, is now posted to the Investor Relations section of Viasat’s website. As previously announced, Viasat will host a conference call today, Tuesday, May 20, 2025 at 2:30 p.m. Pacific Time / 5:30 p.m. Eastern Time. The dial in numbers for the conference are U.S. (800) 715-9871 and International (646) 307-1963. Please reference conference ID 9104119. Participants can also listen to the live webcast from the Investor Relations section of the Viasat website. The call will be archived and available on the site for approximately one month immediately following the conference call. About...

Continue reading

INVO Fertility Announces First Quarter 2025 Financial Results

Company now exclusively focused on the growing fertility market following the April 2025 announcement to divest a majority stake in Naya Therapeutics SARASOTA, Fla., May 20, 2025 (GLOBE NEWSWIRE) — INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced first quarter 2025 financial results. Q1 2025 Financial Highlights (all metrics compared to Q1 2024 unless otherwise noted)Revenue was $1,637,185, an increase of 4% compared to $1,576,286. Consolidated clinic revenue from the Company’s INVO Center in Atlanta, Georgia, and fertility clinic in Madison, Wisconsin, increased 5% to $1,621,553,...

Continue reading

Currenc Group Inc. Announces First Quarter 2025 Financial Results

SINGAPORE, May 20, 2025 (GLOBE NEWSWIRE) — Currenc Group Inc. (Nasdaq: CURR) (“Currenc” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (AI) solutions, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial HighlightsTotal Processing Value (TPV) through Tranglo was US$1.30 billion for the first quarter of 2025, decreasing by 3.7% year-over-year. Total number of transactions decreased to 2.77 million for the first quarter of 2025 from 2.94 million for the same period of 2024. The decline in TPV was mainly due to the decline in business volume from the Hong Kong market. Total revenues excluding TNG Asia and GEA1 were US$10.0 million for the first quarter of 2025, representing a year-over-year decrease of 11.5%,...

Continue reading

Daily Journal Corporation Announces Financial Results for the six Months ended March 31, 2025

Contact: Tu To                                                 (213) 229-5436 LOS ANGELES, May 20, 2025 (GLOBE NEWSWIRE) — During the six months ended March 31, 2025, Daily Journal Corporation (NASDAQ:DJCO) had consolidated revenues of $35,880,000 as compared to $32,564,000 in the prior year period. This increase of $3,316,000 was primarily from increases in (i) Journal Technologies’ license and maintenance fees of $1,615,000 and other public service fees of $2,467,000, partially offset by decreased consulting fees of $1,238,000, and (ii) the Traditional Business’ advertising revenues of $441,000 and advertising service fees and other of $98,000. The Traditional Business’ pretax income increased by $310,000 to $1,171,000 from $861,000. This increase primarily resulted from increased revenues of $472,000. Journal Technologies’ business...

Continue reading

ES Bancshares, Inc. Announces the Receipt of the First Installment of Its Employee Retention Tax Credit

STATEN ISLAND, N.Y., May 20, 2025 (GLOBE NEWSWIRE) — ES Bancshares, Inc. (OTCQX: ESBS) (the “Company”) the holding company for Empire State Bank, (the “Bank”) today reported that the Company received a check for the first installment of $268 thousand of its Employee Retention Tax Credit. The first installment will be reported in our second quarter 2025 earnings results. The Bank filed a claim in 2023 to the Internal Revenue Service (“IRS”) for $1.2 million, plus applicable interest, in Employee Retention Credits (“ERC”) for the years 2020 and 2021. ERC are a refundable payroll tax credit for eligible businesses that paid qualified wages during the COVID-19 pandemic. ERC are generally considered non-taxable income but also require the Company to file amended tax returns for 2020 and 2021 to reduce the associated payroll tax deductions...

Continue reading

Roche provides update on FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

Columvi is the first bispecific antibody to show a statistically significant and clinically meaningful 41% survival benefit in R/R DLBCL in the phase III STARGLO study1,2 There is an urgent need for effective, immediately available therapies that are broadly accessible to people with transplant-ineligible R/R DLBCL This first-of-its-kind Columvi combination could provide a much-needed, off-the-shelf and fixed-duration treatment option for patients who face poor prognosis The clinical and disease characteristics of the overall population enrolled in this multiregional clinical trial are representative and applicable to US patientsBasel, 20 May 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) discussed the supplemental Biologics License...

Continue reading

FLUENT Launches KNACK Whole Flower Brand in Florida, Expanding New York Line to the Sunshine State

TAMPA, Fla., May 20, 2025 (GLOBE NEWSWIRE) — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a national cannabis company operating under the FLUENT™ brand, proudly announces the Florida launch of KNACK, its whole flower brand already trusted by New York consumers. Featuring a curated, rotating selection of hybrid, indica, and sativa strains in a 3.5-gram format, KNACK is now available at all 35 FLUENT dispensaries across Florida. KNACK originally debuted in New York, where it quickly gained traction for delivering high-quality, flavorful, and affordable flower to everyday consumers. The brand is also available at third-party dispensaries in New York via ENTOURAGE wholesale platform. The introduction of KNACK in Florida represents a milestone in FLUENT’s ongoing evolution and renewed focus on raising...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.